<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-49">
 <label>49</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Oldenburg</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Mahlangu</surname>
    <given-names>JN</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>B</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Emicizumab Prophylaxis in Hemophilia A with Inhibitors.</article-title>
  <source>
   <italic>N Engl J Med.</italic>
  </source>
  <year>2017</year>;
  <volume>377</volume>(
  <issue>9</issue>):
  <fpage>809</fpage>â€“
  <lpage>818</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1703068</pub-id>
  <?supplied-pmid 28691557?>
  <pub-id pub-id-type="pmid">28691557</pub-id>
 </mixed-citation>
 <note>
  <p>
   <ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/727795752" xmlns:xlink="http://www.w3.org/1999/xlink">F1000 Recommendation</ext-link>
  </p>
 </note>
</ref>
